Elsevier

Biochemical Pharmacology

Volume 43, Issue 5, 3 March 1992, Pages 1053-1060
Biochemical Pharmacology

Formation of a prostaglandin A2-glutathione conjugate in L1210 mouse leukemia cells

https://doi.org/10.1016/0006-2952(92)90612-MGet rights and content

Abstract

Prostaglandins containing a cyclopentenone moiety are potent antiviral and antigrowth compounds. Some evidence indicates that these prostaglandins are conjugated to glutathione by cells. However, the metabolism of one group, the prostaglandins of the A type, is unclear due to conflicting reports. We studied the uptake and metabolism of prostaglandin A2 (PGA2) in mouse L1210 leukemia and L929 fibroblast cell lines in which this prostaglandin has antiviral and antigrowth effects. Both cell types took up the PGA2 and then metabolized it to a more polar compound. Inside L1210 cells, PGA2 was initially conjugated to glutathione and then reduced at the 9-keto position to form 9-OH-PGA2-GSH. The 9-OH-PGA2-GSH was then secreted from the cells and apparently degraded to form the CysGly and Cys derivatives. Intracellular glutathione was decreased markedly by the addition of the PGA2 in L1210 and L929 cells. This result confirms that conjugation of PGA2 to glutathione occurs in both cell types. Formation of the 9-OH-PGA2-GSH and other glutathione-related conjugates was prevented when glutathione was depleted by growth in buthionine sulfoximine. The glutathione-depleted cells were insensitive to the cytotoxicity of the PGA2, suggesting that one of the glutathione-related conjugates may be involved in the cytotoxicity of PGA2. These results end the controversy over the metabolism of PGA2 and suggest mechanisms for its antiviral and antigrowth actions.

References (44)

  • MG Santoro et al.

    Inhibition of virus protein glycosylation as the mechanism of the antiviral action of prostaglandin A in Sendai virus-infected cells

    J Gen Virol

    (1989)
  • MG Santoro et al.

    Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein

    J Gen Virol

    (1983)
  • J Benavente et al.

    Selective inhibition of viral gene expression as the mechanism of the antiviral action of PGA1 in vaccinia virus-infected cells

    J Gen Virol

    (1984)
  • N Yamamoto et al.

    Mechanism of inhibition of herpes simplex virus replication by Δ7-prostaglandin A1 and Δ12-prostaglandin J2

    Biochem Biophys Res Commun

    (1987)
  • H Ankel et al.

    Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: A unique effect unrelated to interferon

    J Gen Virol

    (1985)
  • M Fukushima et al.

    9-Deoxyl-Δ9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities

    Biochem Biophys Res Commun

    (1982)
  • KV Honn et al.

    Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: Comparison with chemotherapeutic agents

    Biochem Biophys Res Commun

    (1979)
  • KV Honn et al.

    Prostaglandin analogs as inhibitors of tumor cell DNA synthesis

  • MD Bregman et al.

    Prostaglandin A1, and E1, inhibit the plating efficiency and proliferation of murine melanoma cells (Cloudman S-91) in soft agar

    Biochem Biophys Res Commun

    (1982)
  • A Honda et al.

    Antiproliferative and cytotoxic effects of newly discovered halogenated coral prostanoids from the Japanese stolonifer Clavularia viridis on human myeloid leukemic cells in culture

    Mol Pharmacol

    (1987)
  • MG Santoro et al.

    Modulation of the growth of a human erythroleukemic cell line (K562) by prostaglandins: Antiproliferative action of prostaglandin A

    Cancer Res

    (1986)
  • MD Gregman et al.

    Inhibition of human malignant melanoma colony-forming cells in vitro by prostaglandin A1

    Cancer Res

    (1983)
  • KV Honn et al.

    Requirement of a reactive α,β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by “A” series prostaglandins

    Biochem Biophys Res Commun

    (1985)
  • J Atsmon et al.

    Conjugation of 9-deoxy-Δ9,Δ12(E)- prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion

    Cancer Res

    (1990)
  • L Bito et al.

    Impermeability of rabbit erythrocytes to prostaglandins

    Am J Physiol

    (1975)
  • LM Cagen et al.

    Formation of glutathione conjugates of prostaglandin A1 in human red blood cells

    J Biol Chem

    (1976)
  • JB Smith et al.

    Uptake and inactivation of A-type prostaglandins by human red cells

    Prostaglandins

    (1975)
  • LE Heasley et al.

    Prostaglandin A1 metabolism and inhibition of cyclic AMP extrusion by avian erythrocytes

    J Biol Chem

    (1985)
  • J Atsmon et al.

    Formation of thiol conjugates of 9-deoxy-Δ9,Δ12(E)-prostaglandin D2 and Δ12(E)-prostaglandin D2

    Biochemistry

    (1990)
  • S Narumiya et al.

    Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and Δ12-prostaglandin J 2 in nuclei

    J Pharmacol Exp Ther

    (1987)
  • K Ohno et al.

    Site and mechanism of growth inhibition by prostaglandins. IV. Effect of cyclopentenone prostaglandins on cell cycle progression of G1-enriched HeLa S3 cells

    J Pharmacol Exp Ther

    (1988)
  • S Narumiya et al.

    Site and mechanism of growth inhibition by prostaglandins. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition

    J Pharmacol Exp Ther

    (1986)

    • Cited by (0)

    View full text
    Copyright © 1992 Published by Elsevier Inc.